Please assess the completion status of the following clinical trial:

Trial Title: Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 6 mths to 18 years;~* Signs and symptoms of dehydration for less than a week~* Diagnosis of acute gastroenteritis, dehydration, vomiting, and/or diarrhea;~* Patient able to drink from bottle and/or cup;~* Per clinician's judgment, patient needs rehydration with IV solution.~Exclusion Criteria:~* Chronic disease that includes but not limited to TB, HIV, congenital heart disease with hemodynamic consequences, metabolic disease, cerebral palsy, adrenal hyperplasia, renal tubular acidosis, and nephropathy;~* Vomiting due to head trauma;~* Severe hydration;~* Diabetic ketoacidosis;~* Bloody diarrhea;~* Diarrhea for more than a week;~* Malnutrition;~* Burns;~* Pneumonia;~* Meningitis;~* History of seizures;~* Absent bowel sounds;~* Not able to drink from bottle or cup;~* Previous allergic reaction to citrate or other food coloring particles/formulation;~* Parent/legal guardian refusing to participate.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- Standard IV Rehydration Therapy (Type: ACTIVE_COMPARATOR): Patients randomized into the IV rehydration group will receive a Normal Saline bolus of IVF (usually 20 mL/kg) which is the standard therapy up to 24 hrs or as needed depending on patient's weight
- Oral Rehydration Therapy (ORT) (Type: EXPERIMENTAL): Patients randomized into the oral rehydration group will receive the oral Speedlyte product instead of the IV rehydration therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).